FDA authorizes emergency use for Novavax Covid-19 vaccine for ages 12 and 17
August 20, 2022 at 16:06 PM EDT
Novavax announced on Saturday that its Covid-19 vaccine has been authorized for emergency use by the FDA for adolescents between the ages of 12 and 17.
